CalcMyPeptide
All ProtocolsIntermediate

Anti-Aging & Cellular Longevity

Target biological aging mechanisms by optimizing growth hormone, activating telomerase, and altering gene expression toward youthful patterns.

Duration

3-6 months (cyclical)

First Results

4-8 weeks

Peptides in Stack

5

1Overview

Within 4-8 weeks, users typically experience profoundly improved sleep architecture, rapid exercise recovery, and noticeable skin/hair improvements. Long-term cyclical use drives tissue repair, telomere maintenance, and sustained vitality. Khavinson longitudinal studies observed reduced mortality in elderly cohorts receiving Epithalon over 6-12 years.

Ideal Candidates

  • Adults 35+ noticing signs of aging (energy decline, slower recovery, skin elasticity loss)
  • Individuals focused on proactive biohacking and healthspan extension
  • Those dealing with accumulated oxidative stress and chronic fatigue

Contraindications

  • Active cancer or history of cancer (due to growth-promoting pathways)
  • Pregnant or breastfeeding women
  • Uncontrolled systemic autoimmune conditions

2The Science

Biological aging is driven by four converging mechanisms: telomere shortening (limiting cell division), declining GH secretion (reducing tissue repair capacity), shifting gene expression toward pro-inflammatory states, and thymic involution. This protocol intervenes across all four pathways simultaneously with targeted peptides rather than single-mechanism interventions.

Biological Rationale

After age 30, endogenous GH declines ~14% per decade. By 60, most adults produce less than 25% of youthful GH output. Telomere length decreases 20-40 base pairs/year. NAD+ levels decline ~50% between ages 40-60. This protocol addresses each axis concurrently.


3Clinical Evidence

Moderate Evidence
15 human studies200 animal studies50 in vitro

Key Findings

1

Epithalon induced telomerase activity and telomere elongation in human fibroblasts, exceeding the Hayflick limit

Khavinson et al., 2003DOI ↗

2

Epithalon associated with normalized melatonin secretion and reduced mortality in elderly (60-80) over 6-12 year follow-up

St. Petersburg Institute of Bioregulation and Gerontology

3

GHK-Cu modulates 4,000+ genes, shifting genomic activity from aged to youthful expression states

Pickart et al., skin biology studies

4

CJC-1295/Ipamorelin produces dose-dependent GH elevations without significant cortisol or prolactin effects

Multiple Phase 1/2 studies

5

NAD+ precursors restore sirtuin activity and improve age-related metabolic decline

Multiple clinical studies, 2020-2024

Study Limitations

  • Epithalon data primarily from one group (Khavinson); independent replication limited
  • CJC-1295/Ipamorelin not FDA-approved; data from off-label clinical use
  • Long-term telomerase activation safety requires further study (theoretical cancer risk)
  • NAD+ delivery route significantly affects bioavailability; optimal method debated
  • GHK-Cu injectable human data limited vs. extensive topical research

3The Peptide Stack

EP

Induces telomerase activity in human somatic cells. Khavinson et al. (2003) demonstrated telomere elongation in human fibroblasts and normalized melatonin synthesis in elderly patients.

Mechanism: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) upregulating hTERT mRNA expression. Also restores circadian melatonin via pineal gland.

Half-life: ~2-4 hours (estimated)Dose range: 5-10 mg/day
CJ

CJC-1295 (no DAC)

View Profile →

GHRH analog restoring pulsatile GH release from anterior pituitary without the receptor desensitization seen with continuous exogenous GH.

Mechanism: Binds GHRH receptors on somatotroph cells. The no-DAC variant (~30 min half-life) preserves natural pulsatile patterns.

Half-life: ~30 minutesDose range: 100-300 mcg/injection
IP

Selective ghrelin receptor (GHS-R1a) agonist amplifying GH pulses without elevating cortisol, prolactin, or aldosterone—the cleanest GH secretagogue.

Mechanism: Binds GHS-R1a on the pituitary for immediate robust GH pulses. High selectivity minimizes side effects vs. GHRP-6/GHRP-2.

Half-life: ~2 hoursDose range: 100-300 mcg/injection
GH

Modulates expression of over 4,000 genes toward youthful patterns—rebuilding collagen, suppressing inflammatory networks, and accelerating tissue repair.

Mechanism: Copper-binding tripeptide acting as an epigenetic modulator. Upregulates collagen synthesis, nerve growth, and antioxidant defense genes.

Half-life: ~1-2 hours (estimated)Dose range: 1-3 mg/day (SC) or topical
NA

Restores the NAD+ pool (declines ~50% ages 40-60), providing essential substrate for sirtuin activation (SIRT1-7), PARP DNA repair, and mitochondrial energy production.

Mechanism: Directly replenishes nicotinamide adenine dinucleotide. Sirtuins are NAD+-dependent deacetylases regulating mitochondrial biogenesis and stress resistance.

Half-life: ~45 minutes (IV)Dose range: 50-250 mg (SubQ) or 250-1000 mg (IV)

4Protocol Tiers

Foundational Baseline (GH Optimization)

Focuses entirely on restoring endogenous Growth Hormone (GH) levels to combat biological decline.

Duration
8-12 weeks
Frequency: Daily (5 days on, 2 days off recommended to prevent desensitization)
Timing: 30-45 minutes before bed on an empty stomach
Ipamorelin100-200 mcg
Timing: Administered in the same syringe as CJC-1295 prior to bed
Clinical Note: Fasting 2-3 hours before injection minimizes insulin interference with the GH pulse.

The Rejuvenation Stack

Incorporates cellular senescence targeting and DNA repair mechanisms.

Duration
10-20 day "bursts"
Frequency: Daily during burst phases
Epitalon5-10 mg
Timing: Morning
Clinical Note: Typically run in short bursts 2-3 times per year.
GHK-Cu1.5-2 mg
Timing: Any time of day
Clinical Note: Can be run continuously or overlapping with GH optimization.

5Lifestyle Integration

Peptides are one input in a larger system. Without these non-negotiable lifestyle factors, even the best protocol will underperform.

🏋️Training

Prioritize Zone 2 cardio for mitochondrial efficiency combined with 2-3 days of resistance training to preserve lean mass and provide the stimulus for GH-induced hypertrophy.

🥗Nutrition

Maintain moderate protein intake to support tissue repair without overstimulating mTOR pathways constantly. Focus on intermittent fasting (e.g., 16:8) to naturally boost GH and encourage autophagy.

🌙Sleep

Sleep is the cornerstone. GH peaks in early deep sleep cycles; utilizing CJC/Ipamorelin right before bed exploits and amplifies this natural physiological spike.

🧘Stress Management

Chronic cortisol directly antagonizes GH production and accelerates telomere degradation. Dedicated parasympathetic activation (breathwork, meditation) is mandatory.

6Timeline & Expectations

Weeks 1-3

What You'll NoticeProfoundly deeper sleep, more vivid dreams, and slight increases in daytime energy.
What's Happening BiologicallyExogenous peptides are increasing the amplitude of nightly GH pulses, beginning to trigger systemic cellular signaling shifts.

Weeks 4-8

What You'll NoticeNoticeably faster recovery from workouts, improvements in skin elasticity, and sustained mental clarity.
What's Happening BiologicallyIGF-1 reaches new steady-state plateaus; GHK-Cu begins actively modulating genomic expression toward repair states.

Months 3-6

What You'll NoticeSignificant body recomposition (increased lean mass, lower adiposity), looking visibly younger.
What's Happening BiologicallyBiological age markers begin to definitively shift; telomere maintenance pathways are fully activated by short-course Epitalon bursts.

7Monitoring & Safety

Key Metrics to Track

Serum IGF-1Monitor every 8-12 weeks; target the upper quartile for your age group, avoiding supraphysiological levels.
hs-CRP (Inflammation)Should remain <1.0 mg/L as the anti-inflammatory effects of the protocol compound.

Troubleshooting

Water retention or minor joint aching
Possible Causes
  • Normal initial physiological adaptation to higher GH
  • Dose is too aggressive
Solutions
  • Reduce dose by 30%
  • Ensure adequate hydration and electrolyte balance
  • Typically resolves naturally in 2 weeks
Disrupted sleep initially
Possible Causes
  • Dosing too close to bedtime
  • Over-amplified GH pulse causing vivid dreaming
Solutions
  • Shift administration to 60-90 minutes prior to bed rather than immediately before

8Further Reading

Dive deeper into the individual peptides and methodologies behind this protocol.